Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Ocular Surface Optical Coherence Tomography

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 1 (1)

Trial Status

Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT06257355Phase 1RecruitingPrimary

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars

NCT04649177Not ApplicableCompleted

Pilot Study to Investigate the Feasibility, Reliability and Efficacy of Utilizing OCT to Automate PROSE Fitting

Showing all 2 trials

Research Network

Common Treatments

  • Ocular Surface Optical Coherence Tomography1
  • Csb001 Ophthalmic Solution 011

Active Sponsors

  • Claris Biotherapeutics, Inc.1
  • EYEdeal scanning, LTC1
  • Boston Sight1

Top Investigators

Related Conditions

  • Pellucid Marginal Corneal Degeneration1
  • Keratoconus1
  • Dry Eye Syndromes1
  • Ectasia1
  • Ocular Surface Disease1

Activity Timeline